Cholestatic Hepatitis From Erythromycin Ethylsuccinate. Report of Two Cases

Diehl, Anna Mac; Latham, Patricia S.; Boitnott, J. K.; Mann, Jasdeep; Maddrey, W. C.

doi:10.1016/s0022-5347(17)49892-2

Search citation statements

Order By: Relevance

Paper Sections

Select...

Hybridization Studies1

Erythromycin Estolate1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1986

2002

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Massive hepatic necroses have rarely been seen in adults [1,2] and in children without immunodeficiencies [10,15]. Histological examination of the liver in our patient suggested EBV as a cause of the liver disease, there were no indications of drug-induced liver disease [7,14,21,27]. .…”

Section: Hybridization Studiesmentioning

confidence: 58%

Demonstration of Epstein-Barr virus DNA in a previously healthy boy with fulminant hepatic failure

Deutsch¹,

Wolf

Becker

et al. 1986

Eur J Pediatr

View full text Add to dashboard Cite

show abstract

Section: Hybridization Studiesmentioning

confidence: 58%

Demonstration of Epstein-Barr virus DNA in a previously healthy boy with fulminant hepatic failure

Deutsch¹,

Wolf

Becker

et al. 1986

Eur J Pediatr

View full text Add to dashboard Cite

show abstract

“…Cross‐reactivity to other erythromycin derivatives has also been reported. Symptoms and laboratory findings usually subside within a few days of drug withdrawal (40).…”

Section: Erythromycin Estolatementioning

confidence: 99%

Renal Transplantation Update Series Editors: V. Ram Peddi and M. Roy First: Hepatobiliary Diseases After Kidney Transplantation Unrelated to Classic Hepatitis Virus

Ahsan¹,

Rao

2002

Seminars in Dialysis

View full text Add to dashboard Cite

Multiple studies during the past decades have identified chronic liver disease as an important cause of morbidity and mortality in kidney transplant recipients. It has been reported that up to 25% of patients will have some degree of abnormal liver functions during the immediate posttransplant period. In these patients, liver failure has been implicated as the cause of death in approximately 30% of the long-term survivors. While infections from hepatitis virus remain the main cause of ongoing liver damage, many other opportunistic infections with various potential to alter liver function have also been identified. In addition, posttransplant patients are also exposed to hepatotoxic adverse effects of many pharmacotherapeutics including immunosuppressive and nonimmunosuppressive agents. Since there are numerous reports dealing with classic viral hepatitis after kidney transplantation, this review primarily focuses on post-kidney transplant liver diseases which are not due to classic hepatitis viruses.

show abstract

Cholestatic Hepatitis From Erythromycin Ethylsuccinate. Report of Two Cases

Cited by 2 publications

References 0 publications

Demonstration of Epstein-Barr virus DNA in a previously healthy boy with fulminant hepatic failure

Demonstration of Epstein-Barr virus DNA in a previously healthy boy with fulminant hepatic failure

Renal Transplantation Update Series Editors: V. Ram Peddi and M. Roy First: Hepatobiliary Diseases After Kidney Transplantation Unrelated to Classic Hepatitis Virus

Contact Info

Product

Resources

About

Cholestatic Hepatitis From Erythromycin Ethylsuccinate. Report of Two Cases

Cited by 2 publications

References 0 publications

Demonstration of Epstein-Barr virus DNA in a previously healthy boy with fulminant hepatic failure

Demonstration of Epstein-Barr virus DNA in a previously healthy boy with fulminant hepatic failure

Renal Transplantation Update Series Editors: V. Ram Peddi and M. Roy First: Hepatobiliary Diseases After Kidney Transplantation Unrelated to Classic Hepatitis Virus

Contact Info

Product

Resources

About

Renal Transplantation Update Series Editors: V. Ram Peddi and M. Roy First: Hepatobiliary Diseases After Kidney Transplantation Unrelated to Classic Hepatitis Virus